New leadership at Novo Nordisk for Greece and Cyprus
The pharmaceutical company Novo Nordisk recently announced a significant change in its management team for the region of Greece and Cyprus. Myriam Mezher is taking on the position of Head, assuming responsibility for the strategic planning and operations of the company in these two markets.
Ms. Mezher possesses many years of experience in the pharmaceutical sector and has worked in various positions of responsibility within the organization. Her appointment is part of the company's effort to strengthen its presence in the region and continue the growth of its operations.
Novo Nordisk is globally known for the research and production of medicines, primarily for diabetes and other chronic conditions. Its presence in the Greek market is considered crucial for patient access to modern therapeutic solutions.
With the new management, the company aims to continue its collaboration with health authorities in Greece and Cyprus. The goal is to improve patient care and promote innovation in the health sector, while maintaining high quality standards in the services provided.